Marimed (MRMD) Gross Margin (2011 - 2026)

Marimed (MRMD) has 16 years of Gross Margin data on file, last reported at 38.69% in Q1 2026.

• On a quarterly basis, Gross Margin fell 111.0% year-over-year to 38.69% in Q1 2026; TTM through Mar 2026 was 36.02%, a 289.0% decrease from a year earlier, with the FY2025 full-year figure at 36.22%, down 349.0% from the prior year.
• Gross Margin for Q1 2026 stood at 38.69%, up from 25.21% in the prior quarter.
• Over the last five years, Gross Margin for MRMD reached as high as 54.27% in Q1 2022 and fell as low as 25.21% in Q4 2025.
• Historically, Gross Margin has averaged 41.91% across 5 years, with a median of 43.4% in 2023.
• On a YoY basis, Gross Margin climbed as much as 76 bps in 2022 and fell as far as 1410 bps in 2022.
• Year by year, Gross Margin stood at 44.13% in 2022, then rose by 1 bps to 44.52% in 2023, then slipped by 27 bps to 32.49% in 2024, then retreated by 22 bps to 25.21% in 2025, then jumped by 53 bps to 38.69% in 2026.
• Per Business Quant data, the three most recent Gross Margin figures were 38.69% in Q1 2026, 25.21% in Q4 2025, and 40.14% in Q3 2025.